Literature DB >> 15150306

Familial clustering of Hodgkin lymphoma and multiple sclerosis.

Henrik Hjalgrim1, Søren Rasmussen, Klaus Rostgaard, Nete Munk Nielsen, Nils Koch-Henriksen, Lars Munksgaard, Hans H Storm, Mads Melbye.   

Abstract

BACKGROUND: Epidemiologic similarities between Hodgkin lymphoma in young adults (i.e., between 15 and 44 years old) and multiple sclerosis have led to the suggestion that these diseases may have related etiologies. Previous investigations have not supported this hypothesis, but the negative results could have been caused by methodologic problems. We therefore assessed the risk of developing Hodgkin lymphoma for patients with multiple sclerosis and for their families and the risk of developing multiple sclerosis for patients with Hodgkin lymphoma and for their families.
METHODS: We identified 11,790 patients with multiple sclerosis and 19,599 of their first-degree relatives in Danish population-based registers and followed them for the occurrence of Hodgkin lymphoma. Analogously, we identified 4381 patients with Hodgkin lymphoma and 7388 of their first-degree relatives and followed them for the occurrence of multiple sclerosis. The relative risks (RRs) of Hodgkin lymphoma and multiple sclerosis were expressed as standardized incidence ratios (i.e., the ratio between observed and expected numbers of outcomes based on age, sex, and period-specific incidence rates). All statistical tests were two-sided.
RESULTS: Overall, six cases of Hodgkin lymphoma were identified in patients with multiple sclerosis (RR for Hodgkin lymphoma = 1.40, 95% confidence interval [CI] = 0.63 to 3.12), two of which occurred in young adults (RR = 1.59, 95% CI = 0.40 to 6.37). The risk of young-adult-onset Hodgkin lymphoma was statistically significantly increased in the first-degree relatives of patients with multiple sclerosis (RR = 1.93, 95% CI = 1.01 to 3.71; n = 9 such lymphomas). Two cases of multiple sclerosis were identified among young adult patients with Hodgkin lymphoma (RR for multiple sclerosis = 0.82, 95% CI = 0.20 to 3.27), and the risk for multiple sclerosis was statistically significantly increased in their first-degree relatives (RR = 2.76, 95% CI = 1.44 to 5.31; n = 9 such multiple sclerosis cases).
CONCLUSION: The observed familial clustering of multiple sclerosis and young-adult-onset Hodgkin lymphoma is consistent with the hypothesis that the two conditions share environmental and/or constitutional etiologies.

Entities:  

Mesh:

Year:  2004        PMID: 15150306     DOI: 10.1093/jnci/djh135

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries.

Authors:  Ola Landgren; Eric A Engels; Neil E Caporaso; Gloria Gridley; Lene Mellemkjaer; Kari Hemminki; Martha S Linet; Lynn R Goldin
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

Review 2.  Hodgkin lymphoma: an update on its biology with new insights into classification.

Authors:  Haresh Mani; Elaine S Jaffe
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

Review 3.  Cancer and neurodegeneration: between the devil and the deep blue sea.

Authors:  Hélène Plun-Favreau; Patrick A Lewis; John Hardy; L Miguel Martins; Nicholas W Wood
Journal:  PLoS Genet       Date:  2010-12-23       Impact factor: 5.917

Review 4.  A systematic review of the incidence and prevalence of cancer in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Stephen C Reingold; Gary Cutter
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 5.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

6.  Allergic disease, corticosteroid use, and risk of Hodgkin lymphoma: A United Kingdom nationwide case-control study.

Authors:  Meena Rafiq; Andrew Hayward; Charlotte Warren-Gash; Spiros Denaxas; Arturo Gonzalez-Izquierdo; Georgios Lyratzopoulos; Sara Thomas
Journal:  J Allergy Clin Immunol       Date:  2019-11-12       Impact factor: 10.793

Review 7.  CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.

Authors:  Manuel Ruiz-Pablos
Journal:  Pathogens       Date:  2022-07-25

8.  Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.

Authors:  Scott Montgomery; Mohammadhossein Hajiebrahimi; Sarah Burkill; Jan Hillert; Tomas Olsson; Shahram Bahmanyar
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-04-14

9.  Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.

Authors:  Pouya Khankhanian; Wendy Cozen; Daniel S Himmelstein; Lohith Madireddy; Lennox Din; Anke van den Berg; Takuya Matsushita; Sally L Glaser; Jayaji M Moré; Karin E Smedby; Sergio E Baranzini; Thomas M Mack; Antoine Lizée; Silvia de Sanjosé; Pierre-Antoine Gourraud; Alexandra Nieters; Stephen L Hauser; Pierluigi Cocco; Marc Maynadié; Lenka Foretová; Anthony Staines; Manon Delahaye-Sourdeix; Dalin Li; Smita Bhatia; Mads Melbye; Kenan Onel; Ruth Jarrett; James D McKay; Jorge R Oksenberg; Henrik Hjalgrim
Journal:  Int J Epidemiol       Date:  2016-03-12       Impact factor: 7.196

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.